Subepidermal blistering disease acquired autoantibody against laminin 332 during treatment for bullous pemphigoid.
Emi MashimaYu SawadaSanehito HaruyamaEtsuko OkadaNorito IshiiMotonobu NakamuraPublished in: The Journal of dermatology (2020)
Keyphrases